Allison L Naleway Brad Crane Ning Smith Matthew F Daley James Donahue Julianne Gee Sharon K Greene Theresa Harrington Lisa A Jackson Nicola P Klein Hung Fu Tseng Claudia Vellozzi Eric S Weintraub Vaccine Safety Datalink
10.1016/j.vaccine.2015.10.006
Vaccine
2016 Jan 2;34(1):167-71.
adolescents human papillomavirus vaccine safety venous thromboembolism
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/26549361/
Drug-Related Side Effects and Adverse Reactions / epidemiology Drug-Related Side Effects and Adverse Reactions / pathology Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / administration & dosage Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / adverse effects Venous Thromboembolism / chemically induced Venous Thromboembolism / epidemiology
Drug-Related Side Effects and Adverse Reactions / epidemiology Drug-Related Side Effects and Adverse Reactions / pathology Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / administration & dosage Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 / adverse effects Venous Thromboembolism / chemically induced Venous Thromboembolism / epidemiology Research Support, U.S. Gov't, P.H.S. Adolescent Adult Child Cohort Studies Female Humans Incidence Male Papillomavirus Infections / prevention & control Risk Assessment Young Adult Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
PMC4710959
26549361
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011
2016